Hy2Care

company

About

Hy2Care BV develops a novel technology platform consisting of injectable hydrogels to fight osteoarthritis

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
€6M
Industries
Health Care,Medical,Medical Device
Founded date
Dec 5, 2014
Number Of Employee
1 - 10
Operating Status
Active

Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel.

Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment.
It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€9.71M
Hy2Care has raised a total of €9.71M in funding over 2 rounds. Their latest funding was raised on Jun 6, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 6, 2022 Grant €6M 1 European Innovation Council Detail
May 1, 2019 Series A €3.70M 1 Detail
Mar 10, 2015 Seed €15K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Hy2Care is funded by 3 investors. European Innovation Council and ReumaNederland are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
ReumaNederland Series A
Startupbootcamp Smart Materials Seed